At a glance
ClinicalIndex Comparison RecordN/ACompleted· 330 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Silent Threat: How Do Preoperative Albumin Levels Affect Outcomes in Geriatric Cancer Surgery
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital·observational·Posted May 31, 2025·Updated Apr 30, 2026
In Brief
An observational study for Neoplasms and 4 related conditions. Completed, enrolled 330 participants across 1 site.
Detailed Summary
This retrospective, single-center study aims to evaluate the impact of preoperative albumin levels on postoperative outcomes in geriatric patients (aged 65 and above) undergoing cancer surgery. The study will compare postoperative complication rates, length of hospital stay, and intensive care needs between patients with hypoalbuminemia and those with normal albumin levels.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNeoplasms, Aged, Hypoalbuminemia, Postoperative Complications, Malnutrition
CountriesTurkey (Türkiye)
Collaborators--
Timeline
N/ACompletedFinished
2026
Enrollment StartApr 2025
Primary CompletionApr 2025
Study CompletionMay 2025
First PostedMay 2025
TodayJul 2026
First PostedMay 31, 2025
Enrollment StartApr 1, 2025
Primary CompletionApr 30, 2025
Study CompletionMay 10, 2025
TodayJul 2, 2026
Enrollment to primary: 29 daysPosted 1.1 years ago